Dimethyl Fumarate Therapy Significantly Improves the Responsiveness of T Cells in Multiple Sclerosis Patients for Immunoregulation by Regulatory T Cells. [electronic resource]
Producer: 20170424ISSN:- 1422-0067
- Adult
- Animals
- Dimethyl Fumarate -- pharmacology
- Down-Regulation -- drug effects
- Female
- Graft vs Host Disease -- immunology
- Humans
- Lymphocyte Activation -- drug effects
- Male
- Mice
- Middle Aged
- Multiple Sclerosis -- drug therapy
- Receptors, Interleukin-6 -- metabolism
- Spleen -- pathology
- T-Lymphocytes, Regulatory -- drug effects
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.